Centro / Instituto vinculado a la Universidad de Navarra
Centro de Investigación de Medicina Aplicada (CIMA)
Publicaciones (178) Publicaciones en las que ha participado algún/a investigador/a
2018
-
Alterations in Gene and Protein Expression of Cannabinoid CB 2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims
Neurotherapeutics, Vol. 15, Núm. 3, pp. 796-806
-
Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET
BMC Cancer, Vol. 18, Núm. 1
-
A 30-s exposure to ethanol 20% is cytotoxic to human keratinocytes: possible mechanistic link between alcohol-containing mouthwashes and oral cancer
Clinical Oral Investigations, Vol. 22, Núm. 8, pp. 2943-2946
-
A lncRNA GUARDINg genome integrity
Nature Cell Biology, Vol. 20, Núm. 4, pp. 371-372
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity
Nature Communications, Vol. 9, Núm. 1
-
Absence of MHC-II expression by lymph node stromal cells results in autoimmunity
Life Science Alliance, Vol. 1, Núm. 6
-
Adjuvant therapy for colon cancer: Genes, genes. . . And the patient in the center
Clinical Cancer Research, Vol. 24, Núm. 16, pp. 3787-3789
-
Allogeneic mesenchymal stem cells and biomaterials: The perfect match for cardiac repair?
International Journal of Molecular Sciences, Vol. 19, Núm. 10
-
An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria
Human Gene Therapy, Vol. 29, Núm. 4, pp. 480-491
-
An rna toolbox for cancer immunotherapy
Nature Reviews Drug Discovery, Vol. 17, Núm. 10, pp. 751-767
-
Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death
Neurotherapeutics, Vol. 15, Núm. 4, pp. 1063-1081
-
Antigen phagocytosis by B cells is required for a potent humoral response
EMBO Reports, Vol. 19, Núm. 9
-
Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells
Journal of Biomedical Materials Research - Part A, Vol. 106, Núm. 2, pp. 377-385
-
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia
Leukemia, Vol. 32, Núm. 4, pp. 874-881
-
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 4, pp. 641-648
-
Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1326-1334
-
Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria
Human Molecular Genetics, Vol. 27, Núm. 21, pp. 3688-3696
-
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial
European Journal of Heart Failure, Vol. 20, Núm. 9, pp. 1290-1299